Granules India 

Granules India Limited is a Hyderabad-headquartered, vertically integrated pharmaceutical manufacturer that presents scale as an industrial product, not as a marketing adjective. On granulesindia.com the company writes a four-decade path from a paracetamol active-pharmaceutical-ingredient plant to a multi-site house that sells APIs, pharmaceutical formulation intermediates, finished dosages, and a speciality book. Vertical integration is the operating sentence: make the molecule, granulate it at a batch size the company treats as a competitive fact, and finish it under the same quality system so a customer can buy a raw, a PFI, or a packed product. Large PFI campaigns are the nameplate claim Granules still uses to say it is a first-line-of-defence high-volume manufacturer rather than a boutique chemist. Research-and-development centres, including work the company has announced with academic partners, sit beside manufacturing excellence and regulatory filings. Geography is written as India plus the United States—plants such as Gagillapur, Bonthapally, Jeedimetla, and Paravada in India, and Chantilly, Virginia, under Granules Pharmaceuticals Inc.—so inspectors and customers meet one quality language in two countries. Own-label international finished dosages sit next to merchant API and PFI so the same chemistry can travel as a partner ingredient or as a Granules-branded pack. Employee counts, ANDA tallies, and country lists belong on the corporate site and in exchange filings; they are cited here only as the company’s own scale markers. Customers are generic houses, own-label buyers, and public-health purchasers who need documented high-volume chemistry, not a consumer brand. Official product information is not medical advice. Labels, licensed indications, and a physician decide what a patient takes. API and PFI pages describe chemistry and capacity for qualified customers; they are not consumer dosing guides. Official Facebook, X, and LinkedIn pages—posted as Granules India—carry plant films, results commentary, and careers colour. They are not adverse-event desks, pharmacy counters, or places to share prescriptions, batch records, or personal health data. Specifications, safety reports, and investor facts belong on granulesindia.com and on the contact routes the company publishes, including mail@granulesindia.com and the pharmacovigilance address on the corporate contact page. Follow the pages for a Hyderabad-rooted manufacturer that still presents API-to-finished vertical integration and large PFI batches as the point of the enterprise, then verify every plant, ANDA, and country claim at the source.